Intracranial Neoplasm clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages 3 years and up
This phase II trial studies how well F-18 fluoroethyltyrosine (fluoroethyltyrosine) works in detecting tumors in participants with intracranial tumors that have come back. Imaging agents, such as fluoroethyltyrosine, may help doctors see the tumor better during a positron emission tomography (PET) scan.
Our lead scientists for Intracranial Neoplasm research studies include Thomas A Hope, MD.